Peroxiredoxin 6 Antibody [G12J13]

Katalog-Nr. F2838

Drucken

Biologische Beschreibung

Spezifität Peroxiredoxin 6 Antibody [G12J13] detektiert endogene Spiegel des gesamten Peroxiredoxin 6 Proteins.
Hintergrund Peroxiredoxin 6 (Prdx6) ist ein charakteristisches 25 kDa 1-Cys-Peroxiredoxin, das in praktisch allen Geweben exprimiert wird, aber besonders stark in der Lunge angereichert ist und einzigartig robuste Peroxidase- und Phospholipase A2 (PLA2)-ähnliche Aktivitäten innerhalb eines einzigen 224-Aminosäuren-Polypeptids kombiniert. Sein N-terminales Thioredoxin-Faltungsdomäne beherbergt das peroxidatische Cys47 in einer hydrophoben Tasche, was eine effiziente Reduktion von H₂O₂, kurzkettigen organischen und Phospholipidhydroperoxiden unter Verwendung von Glutathion (GSH) als Hauptreduktionsmittel ermöglicht, während die ausgeprägte Oberflächen-PLA2-Katalysestelle (His26-Ser32-Asp140-Triade und GDSWG-Motiv) sn-2-Acylketten von oxidierten Phospholipiden hydrolysiert. Prdx6 wechselt zwischen reduzierten Monomeren (die die Peroxidaseaktivität fördern) und oxidierten Dimeren (die die PLA2-Funktion verbessern), was eine schnelle Anpassung an oxidativen und Lipidstress ermöglicht. Durch diesen dualen Mechanismus schützt Prdx6 nicht nur das Redoxgleichgewicht und die Membranintegrität, insbesondere im Lungen-Surfactant-Metabolism, sondern erleichtert auch die vollständige Reparatur durch die Kopplung der PLA2-vermittelten Phospholipidhydrolyse mit der Lysophosphatidylcholin-Acyltransferase (LPCAT)-Reacylierung. Prdx6 moduliert die H₂O₂-Signalgebung und aktiviert die NADPH-Oxidase 2 (Nox2) für entzündliche Reaktionen und interagiert mit Thioredoxin-Netzwerken. Ihre Regulation umfasst die Nrf2-gesteuerte Transkription, pH-abhängige Aktivitätsumschaltung (neutral für Peroxidase, sauer für PLA2), Phosphorylierung und Glutathionylierung, mit stressinduzierter Translokation zu Mitochondrien, Lysosomen oder Plasmamembran. Eine Dysregulation von Prdx6 ist mit multiplen Pathologien verbunden, einschließlich Krebs (über NF-κB-gesteuertes Wachstum, Invasion und Therapieresistenz), Neurodegeneration (Beeinflussung sowohl oxidativer Schäden als auch der Tau-Aggregation), Entzündungen, Osteoporose, Diabetes, Katarakten und Unfruchtbarkeit.

Nutzungsinformationen

Anwendung WB, IHC Verdünnung
WB IHC
1:1000 - 1:10000 1:250 - 1:500
Reaktivität Mouse, Rat, Human
Quelle Rabbit Monoclonal Antibody MW 25 kDa
Lagerpuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Lagerung
(Ab dem Datum des Erhalts)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IHC
Experimental Protocol:
 
Deparaffinization/Rehydration
1. Deparaffinize/hydrate sections:
2. Incubate sections in three washes of xylene for 5 min each.
3. Incubate sections in two washes of 100% ethanol for 10 min each.
4. Incubate sections in two washes of 95% ethanol for 10 min each.
5. Wash sections two times in dH2O for 5 min each.
6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
 
Staining
1. Wash sections in dH2O three times for 5 min each.
2. Incubate sections in 3% hydrogen peroxide for 10 min.
3. Wash sections in dH2O two times for 5 min each.
4. Wash sections in wash buffer for 5 min.
5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
9. Wash sections three times with wash buffer for 5 min each.
10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
12. Immerse slides in dH2O.
13. If desired, counterstain sections with hematoxylin.
14. Wash sections in dH2O two times for 5 min each.
15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
16. Mount sections with coverslips and mounting medium.
 

Referenzen

  • https://pubmed.ncbi.nlm.nih.gov/20919932/
  • https://pubmed.ncbi.nlm.nih.gov/27932289/

Anwendungsdaten

WB

Validiert von Selleck

  • F2838-wb
    Lane 1: 293T, Lane 2: A431, Lane 3: Mouse liver, Lane 4: Rat liver